Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-03-09 @ 7:22 AM
Study NCT ID:
NCT00954460
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2021-05-21
First Post:
2009-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
Sponsor:
Shire
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gaucher Disease, Type 1 | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | VPRIV | View |
| None | Enzyme Replacement Therapy | View |
| None | Gaucher disease | View |
| None | glucocerebrosidase | View |
| None | beta-glucocerebrosidase | View |
| None | Acid beta-glucocerebrosidase | View |
| None | glucosylceramidase | View |
| None | D-glucosyl-N-acylsphingosine glucohydrolase | View |
| None | gene activation | View |
| None | human | View |